AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

PUlmonary REhabilitation in Patients Suffering From Post-PE Syndrome

RecruitingNAAges 18 Years - 90 YearsAllMedical University of Vienna
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is a multicenter, parallel, randomized waitlist-controlled trial that primarily focuses on the short-term benefit of outpatient pulmonary rehabilitation (PR) on patients after acute pulmonary embolism. Patients will be randomized into an intervention and a control group. The intervention group will receive 6 weeks of outpatient PR, while patients in the other treatment arm will serve as a control. After completion of the randomized study, the second arm will undergo PR as well.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Post-PE syndrome (except patients previously diagnosed with CTEPH) diagnosed by any of the following: * Post-PE functional impairment criteria * Post-PE Cardiac Impairment criteria * Chronic Thromboembolic Disease criteria * Possibility of starting rehabilitation between 12 and 36 weeks after the initial event of PE Exclusion Criteria: * CTEPH diagnosis * Chronic pulmonary diseases: COPD, interstitial lung diseases, asthma (only patients with severe asthma defined as a FEV1 โ‰ค 80% will be excluded), a statement on COVID-19 was amended due to the pandemic # * Active cancer * Pregnancy * Myocardial infarction or cardiac surgery one year prior to inclusion * Congenital heart disease, congestive heart failure * History of stroke * Any previous inpatient or outpatient PR Additional criteria that are absolute contraindications for pulmonary rehabilitation * Acute and decompensated disease states with severe functional restrictions of various organ systems (e.g. heart, kidney and liver insufficiency, unstable angina pectoris, hemodynamically unstable arrhythmias, acute spinal cord injury, untreated hormonal disorders, acute psychological disorders) * open tuberculosis * active infectious diseases and acute inflammatory processes * Stressful and time-consuming therapy that significantly impair the ability to rehabilitate (e.g. chemotherapy or radiation therapy after malignancy) * Participants who are not sufficiently resilient due to physical or mental impairment and / or cannot be mobilized and therefore cannot actively use the rehabilitation facility * lack of motivation for therapy * massive incontinence * drugs and alcohol addiction
๐Ÿ’Š

What it tests

  • Rehabilitation
๐Ÿ“

Where

1 site
Therme Wien Med
Vienna, Austria
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy